ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
247.66
+2.62 (1.07%)
At close: May 12, 2025, 4:00 PM
247.66
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT

ResMed Market Cap

ResMed has a market cap or net worth of $36.31 billion as of May 12, 2025. Its market cap has increased by 34.34% in one year.

Market Cap
36.31B
Enterprise Value
36.21B
1-Year Change
34.34%
Ranking
Category
Stock Price
$247.66

Market Cap Chart

Since December 1, 1998, ResMed's market cap has increased from $485.80M to $36.31B, an increase of 7,375.04%. That is a compound annual growth rate of 17.71%.

History

DateMarket Cap% Change
May 9, 202535.93B7.03%
Dec 31, 202433.57B32.68%
Dec 29, 202325.30B-17.01%
Dec 30, 202230.49B-19.68%
Dec 31, 202137.96B23.23%
Dec 31, 202030.80B38.24%
Dec 31, 201922.28B37.32%
Dec 31, 201816.23B35.02%
Dec 29, 201712.02B37.39%
Dec 30, 20168.75B16.66%
Dec 31, 20157.50B-4.09%
Dec 31, 20147.82B16.86%
Dec 31, 20136.69B12.47%
Dec 31, 20125.95B40.80%
Dec 30, 20114.22B-19.35%
Dec 31, 20105.24B33.67%
Dec 31, 20093.92B38.11%
Dec 31, 20082.84B-30.14%
Dec 31, 20074.06B8.50%
Dec 29, 20063.74B38.30%
Dec 30, 20052.71B56.41%
Dec 31, 20041.73B22.93%
Dec 31, 20031.41B39.73%
Dec 31, 20021.01B-41.47%
Dec 31, 20011.72B39.28%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 678.30B
Johnson & Johnson 370.87B
UnitedHealth Group 343.58B
AbbVie 335.74B
Novo Nordisk 292.03B
Abbott Laboratories 229.64B
Novartis AG 213.30B
AstraZeneca 210.42B
Market Cap Rankings